Bapineuzumab

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A humanized monoclonal antibody (IgG1) raised against amyloid beta peptides with Alzheimer disease treatment application. Bapineuzumab recognizes and binds the N-terminal amino acids 1-5 of the amyloid beta peptide, and may be used in a passive immunotherapy treatment.

**Synonyms:** - AAB-001 - Anti-human beta-amyloid Monoclonal Antibody 3D-6 - BAPINEUZUMAB - Humanized 3D-6 Monoclonal Antibody